These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prostaglandin E₂ receptor EP1-mediated phosphorylation of focal adhesion kinase enhances cell adhesion and migration in hepatocellular carcinoma cells. Bai X; Wang J; Zhang L; Ma J; Zhang H; Xia S; Zhang M; Ma X; Guo Y; Rong R; Cheng S; Shu W; Wang Y; Leng J Int J Oncol; 2013 May; 42(5):1833-41. PubMed ID: 23525457 [TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2 promotes migration and adhesion in hepatocellular carcinoma cells. Mayoral R; Fernández-Martínez A; Boscá L; Martín-Sanz P Carcinogenesis; 2005 Apr; 26(4):753-61. PubMed ID: 15661807 [TBL] [Abstract][Full Text] [Related]
6. Active lysyl oxidase (LOX) correlates with focal adhesion kinase (FAK)/paxillin activation and migration in invasive astrocytes. Laczko R; Szauter KM; Jansen MK; Hollosi P; Muranyi M; Molnar J; Fong KS; Hinek A; Csiszar K Neuropathol Appl Neurobiol; 2007 Dec; 33(6):631-43. PubMed ID: 17931358 [TBL] [Abstract][Full Text] [Related]
7. An altered fibronectin matrix induces anoikis of human squamous cell carcinoma cells by suppressing integrin alpha v levels and phosphorylation of FAK and ERK. Kamarajan P; Kapila YL Apoptosis; 2007 Dec; 12(12):2221-31. PubMed ID: 17879163 [TBL] [Abstract][Full Text] [Related]
8. P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation. Ching YP; Leong VY; Lee MF; Xu HT; Jin DY; Ng IO Cancer Res; 2007 Apr; 67(8):3601-8. PubMed ID: 17440071 [TBL] [Abstract][Full Text] [Related]
9. Effects of active and inactive phospholipase D2 on signal transduction, adhesion, migration, invasion, and metastasis in EL4 lymphoma cells. Knoepp SM; Chahal MS; Xie Y; Zhang Z; Brauner DJ; Hallman MA; Robinson SA; Han S; Imai M; Tomlinson S; Meier KE Mol Pharmacol; 2008 Sep; 74(3):574-84. PubMed ID: 18523140 [TBL] [Abstract][Full Text] [Related]
10. MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells. Bessard A; Frémin C; Ezan F; Coutant A; Baffet G J Cell Physiol; 2007 Aug; 212(2):526-36. PubMed ID: 17427199 [TBL] [Abstract][Full Text] [Related]
12. Tissue factor pathway inhibitor (TFPI) interferes with endothelial cell migration by inhibition of both the Erk pathway and focal adhesion proteins. Provençal M; Michaud M; Beaulieu E; Ratel D; Rivard GE; Gingras D; Béliveau R Thromb Haemost; 2008 Mar; 99(3):576-85. PubMed ID: 18327407 [TBL] [Abstract][Full Text] [Related]
13. A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth. Shi Q; Hjelmeland AB; Keir ST; Song L; Wickman S; Jackson D; Ohmori O; Bigner DD; Friedman HS; Rich JN Mol Carcinog; 2007 Jun; 46(6):488-96. PubMed ID: 17219439 [TBL] [Abstract][Full Text] [Related]
14. Migration of renal carcinoma cells is dependent on protein kinase Cdelta via beta1 integrin and focal adhesion kinase. Brenner W; Greber I; Gudejko-Thiel J; Beitz S; Schneider E; Walenta S; Peters K; Unger R; Thüroff JW Int J Oncol; 2008 May; 32(5):1125-31. PubMed ID: 18425341 [TBL] [Abstract][Full Text] [Related]
15. Osteopontin increases migration and MMP-9 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells. Chen YJ; Wei YY; Chen HT; Fong YC; Hsu CJ; Tsai CH; Hsu HC; Liu SH; Tang CH J Cell Physiol; 2009 Oct; 221(1):98-108. PubMed ID: 19475568 [TBL] [Abstract][Full Text] [Related]
16. The effect of epidermal growth factor receptor variant III on glioma cell migration by stimulating ERK phosphorylation through the focal adhesion kinase signaling pathway. Liu M; Yang Y; Wang C; Sun L; Mei C; Yao W; Liu Y; Shi Y; Qiu S; Fan J; Cai X; Zha X Arch Biochem Biophys; 2010 Oct; 502(2):89-95. PubMed ID: 20650261 [TBL] [Abstract][Full Text] [Related]
17. Membrane-type 1 matrix metalloproteinase modulates focal adhesion stability and cell migration. Takino T; Watanabe Y; Matsui M; Miyamori H; Kudo T; Seiki M; Sato H Exp Cell Res; 2006 May; 312(8):1381-9. PubMed ID: 16473349 [TBL] [Abstract][Full Text] [Related]
18. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells. Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520 [TBL] [Abstract][Full Text] [Related]
19. Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma. Madan R; Smolkin MB; Cocker R; Fayyad R; Oktay MH Hum Pathol; 2006 Jan; 37(1):9-15. PubMed ID: 16360410 [TBL] [Abstract][Full Text] [Related]
20. Focal adhesion kinase regulates syndecan-2-mediated tumorigenic activity of HT1080 fibrosarcoma cells. Park H; Han I; Kwon HJ; Oh ES Cancer Res; 2005 Nov; 65(21):9899-905. PubMed ID: 16267014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]